Pulmonx Corp 8-K Summary: Annual Meeting Results
Business Context and Reporting Period
This Form 8-K reports on the 2025 Annual Meeting of Stockholders held by Pulmonx Corporation on May 22, 2025. The meeting addressed the election of directors, ratification of the independent auditor, and an advisory vote on executive compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes and Voting Results
Approximately 82.79% of outstanding shares (33,322,365 shares) were present or represented by proxy. The following proposals were voted upon:
- Proposal 1 (Election of Directors): All three Class II nominees were elected.
- Richard M. Ferrari: 16,967,158 For; 11,954,625 Withheld.
- Daniel P. Florin: 21,067,949 For; 7,853,834 Withheld.
- Steven S. Williamson: 21,336,518 For; 7,585,265 Withheld.
- Proposal 2 (Ratification of Auditor): Stockholders ratified the appointment of BDO USA, P.C.
- For: 33,032,895
- Against: 282,772
- Abstain: 6,698
- Proposal 3 (Executive Compensation): The non-binding advisory vote was approved.
- For: 14,708,726
- Against: 14,202,629
- Abstain: 10,428
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the high number of "Withheld" votes for Director Richard M. Ferrari compared to other nominees.
- Note the narrow margin of approval for the executive compensation vote (Proposal 3), where "For" votes were only slightly higher than "Against" votes.
- Confirm the record date of March 25, 2025, for the 40,247,480 outstanding shares entitled to vote.